Bank Of New York Mellon Corp Vanda Pharmaceuticals Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$6.87 - $10.96 $3.47 Million - $5.54 Million	505,593 New	505,593 $3.74 Million
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $1.39 Million - $1.73 Million	147,014 Added 23.84%	763,605 $7.54 Million
Q2 2022 Aug 15, 2022	SELL	$9.31 - $11.84 $6.17 Million - $7.84 Million	-662,564 Reduced 51.8%	616,591 $6.72 Million
Q1 2022 May 11, 2022	SELL	$10.84 - $16.55 $2.07 Million - $3.16 Million	-190,811 Reduced 12.98%	1,279,155 $14.5 Million
Q4 2021 Feb 11, 2022	BUY	$15.69 - $21.14 $2.83 Million - $3.81 Million	180,437 Added 13.99%	1,469,966 $23.1 Million
Q3 2021 Nov 12, 2021	BUY	$15.35 - $21.27 $3.02 Million - $4.19 Million	196,831 Added 18.01%	1,289,529 $22.1 Million
Q2 2021 Aug 11, 2021	BUY	$15.71 - $21.51 $7.97 Million - $10.9 Million	507,383 Added 86.69%	1,092,698 $23.5 Million
Q1 2021 May 13, 2021	BUY	$13.42 - $20.28 $72,239 - $109,167	5,383 Added 0.93%	585,315 $8.79 Million
Q4 2020 Feb 09, 2021	SELL	$9.77 - $13.81 $247,239 - $349,475	-25,306 Reduced 4.18%	579,932 $7.62 Million
Q3 2020 Nov 12, 2020	SELL	$9.32 - $12.02 $171,040 - $220,591	-18,352 Reduced 2.94%	605,238 $5.85 Million
Q2 2020 Aug 12, 2020	BUY	$9.66 - $12.02 $222,479 - $276,832	23,031 Added 3.83%	623,590 $7.13 Million
Q1 2020 May 06, 2020	SELL	$7.5 - $16.8 $92,512 - $207,228	-12,335 Reduced 2.01%	600,559 $6.22 Million
Q4 2019 Feb 14, 2020	BUY	$12.38 - $17.47 $87,959 - $124,124	7,105 Added 1.17%	612,894 $10.1 Million
Q3 2019 Nov 07, 2019	BUY	$12.27 - $15.79 $131,485 - $169,205	10,716 Added 1.8%	605,789 $8.04 Million
Q2 2019 Aug 12, 2019	SELL	$13.37 - $18.85 $118,284 - $166,765	-8,847 Reduced 1.46%	595,073 $8.39 Million
Q1 2019 May 14, 2019	SELL	$17.59 - $31.05 $509,564 - $899,487	-28,969 Reduced 4.58%	603,920 $11.1 Million
Q4 2018 Feb 11, 2019	BUY	$18.97 - $31.47 $800,875 - $1.33 Million	42,218 Added 7.15%	632,889 $16.5 Million
Q3 2018 Nov 09, 2018	BUY	$18.25 - $23.0 $6.87 Million - $8.65 Million	376,301 Added 175.54%	590,671 $0
Q2 2018 Aug 06, 2018	BUY	$13.95 - $19.15 $136,654 - $187,593	9,796 Added 4.79%	214,370 $4.08 Million
Q1 2018 May 15, 2018	BUY	$14.05 - $20.2 $59,192 - $85,102	4,213 Added 2.1%	204,574 $3.45 Million
Q4 2017 Feb 09, 2018	BUY	$12.85 - $18.1 $2.57 Million - $3.63 Million	200,361	200,361 $3.05 Million

Others Institutions Holding VNDA

# of Institutions

157

Shares Held

44.9M

Call Options Held

165K

Put Options Held

33.6K

Black Rock Inc. New York, NY

8.14M
Shares

$35.9 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.01M
Shares

$17.7 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

3.63M
Shares

$16 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.35M
Shares

$10.4 Million
0.94% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.26M
Shares

$9.97 Million
0.0% of portfolio

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $249M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account